New SCN5A mutation in a SUDEP victim with idiopathic epilepsy

Seizure

Volumn 18, Issue 2, 2009, Pages 158-160

  Aurlien, Dag ^a   Leren, Trond P ^b   Taubøll, Erik ^b,c   Gjerstad, Leif ^b,c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Channelopathy; Idiopathic epilepsy; LQTS

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; UNCLASSIFIED DRUG; VALPROIC ACID; VOLTAGE GATED SODIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL 5 ALPHA;

ANAMNESIS; ARTICLE; AUTOPSY; CASE REPORT; DNA SEQUENCE; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAM; EPILEPSY; FATIGUE; FEMALE; HUMAN; IDIOPATHIC DISEASE; LONG QT SYNDROME; MISSENSE MUTATION; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUDDEN DEATH; TREMOR;

ADOLESCENT; ANTICONVULSANTS; BASE SEQUENCE; DEATH, SUDDEN, CARDIAC; EPILEPSY; FEMALE; HUMANS; LONG QT SYNDROME; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION, MISSENSE; SODIUM CHANNELS; TRIAZINES;

EID: 60649106155     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2008.07.008     Document Type: Article

References (16)

1. Mulley J.C., Scheffer I.E., Petrou S., and Berkovic S.F. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 16 (2003) 171-176
2. Zareba W., and Moss A.J. Long QT syndrome in children. J Electrocardiol 3 suppl. (2001) 167-171
3. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. http://www.hgmd.cf.ac.uk/ac/index.php.
4. Hartmann H.A., Colom L.V., Sutherland M.L., and Noebels J.L. Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain. Nat Neurosci 2 (1999) 593-595
5. Aurlien D., Taubøll E., and Gjerstad L. Lamotrigine in idiopathic epilepsy-increased risk of cardiac death?. Acta Neurol Scand 115 3 (2007) 199-203
6. Berge KE, Haugaa KH, Früh A, Anfinsen OG, Gjesdal K, Siem G, et al. Molecular genetic analysis of long QT syndrome in Norway indicates a high prevalence of heterozygous mutation carriers. Scand J Clin Lab Invest. First published on 18 December 2007. doi:10.1080/0036551070.
7. Nashef L., Hindocha N., and Makoff A. Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms. Epilepsia 48 5 (2007) 859-871
8. Beaufort-Krol G.C., van den Berg M.P., Wilde A.A., van Tintelen J.P., Viersma J.W., Bezzina C.R., et al. Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood. J Am Coll Cardiol 46 (2005) 331-337
9. Vincent G.M. The Long QT and Brugada syndromes: causes of unexpected syncope and sudden cardiac death in children and young adults. Semin Pediatr Neurol 12 (2005) 15-24
10. Pacia S.V., Devinsky O., Luciano D.J., and Vasquez B. The prolonged QT syndrome presenting as epilepsy: a report of two cases and literature review. Neurology 44 (1994) 1408-1410
11. Hunt D.P., and Tang K. Long QT syndrome presenting as epileptic seizures in an adult. Emerg Med J 22 (2005) 600-601
12. Wild E. Déjà vu in neurology. J Neurol 252 (2005) 1-7
13. Blume W.T. Drug effects on EEG. J Clin Neurophysiol 23 (2006) 306-311
14. Stöllberger C., and Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 59 (2004) 51-60
15. Herold T.J.S. Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder. Can J Emerg Med 8 (2006) 361-364
16. Danielsson B.R., Lansdell K., Patmore L., and Tomson T. Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res 63 (2005) 17-25